全文获取类型
收费全文 | 36989篇 |
免费 | 2937篇 |
国内免费 | 85篇 |
专业分类
耳鼻咽喉 | 427篇 |
儿科学 | 923篇 |
妇产科学 | 781篇 |
基础医学 | 4700篇 |
口腔科学 | 638篇 |
临床医学 | 4285篇 |
内科学 | 7271篇 |
皮肤病学 | 480篇 |
神经病学 | 3351篇 |
特种医学 | 1437篇 |
外科学 | 6118篇 |
综合类 | 522篇 |
一般理论 | 68篇 |
预防医学 | 3073篇 |
眼科学 | 945篇 |
药学 | 2586篇 |
中国医学 | 31篇 |
肿瘤学 | 2375篇 |
出版年
2023年 | 311篇 |
2022年 | 550篇 |
2021年 | 1243篇 |
2020年 | 653篇 |
2019年 | 1110篇 |
2018年 | 1234篇 |
2017年 | 901篇 |
2016年 | 964篇 |
2015年 | 1098篇 |
2014年 | 1585篇 |
2013年 | 1867篇 |
2012年 | 3018篇 |
2011年 | 3034篇 |
2010年 | 1590篇 |
2009年 | 1428篇 |
2008年 | 2324篇 |
2007年 | 2307篇 |
2006年 | 2130篇 |
2005年 | 1989篇 |
2004年 | 1817篇 |
2003年 | 1563篇 |
2002年 | 1409篇 |
2001年 | 470篇 |
2000年 | 417篇 |
1999年 | 378篇 |
1998年 | 266篇 |
1997年 | 208篇 |
1996年 | 177篇 |
1995年 | 122篇 |
1994年 | 150篇 |
1993年 | 152篇 |
1992年 | 298篇 |
1991年 | 257篇 |
1990年 | 212篇 |
1989年 | 212篇 |
1988年 | 200篇 |
1987年 | 189篇 |
1986年 | 184篇 |
1985年 | 170篇 |
1984年 | 130篇 |
1983年 | 110篇 |
1982年 | 89篇 |
1981年 | 86篇 |
1980年 | 102篇 |
1979年 | 94篇 |
1978年 | 86篇 |
1977年 | 78篇 |
1976年 | 89篇 |
1973年 | 95篇 |
1972年 | 87篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Patrick W. Keeley Mikayla C. Lebo Jordan D. Vieler Jason J. Kim Ace J. St. John Benjamin E. Reese 《The Journal of neuroscience》2021,41(1):103
Amacrine cells of the retina are conspicuously variable in their morphologies, their population demographics, and their ensuing functions. Vesicular glutamate transporter 3 (VGluT3) amacrine cells are a recently characterized type of amacrine cell exhibiting local dendritic autonomy. The present analysis has examined three features of this VGluT3 population, including their density, local distribution, and dendritic spread, to discern the extent to which these are interrelated, using male and female mice. We first demonstrate that Bax-mediated cell death transforms the mosaic of VGluT3 cells from a random distribution into a regular mosaic. We subsequently examine the relationship between cell density and mosaic regularity across recombinant inbred strains of mice, finding that, although both traits vary across the strains, they exhibit minimal covariation. Other genetic determinants must therefore contribute independently to final cell number and to mosaic order. Using a conditional KO approach, we further demonstrate that Bax acts via the bipolar cell population, rather than cell-intrinsically, to control VGluT3 cell number. Finally, we consider the relationship between the dendritic arbors of single VGluT3 cells and the distribution of their homotypic neighbors. Dendritic field area was found to be independent of Voronoi domain area, while dendritic coverage of single cells was not conserved, simply increasing with the size of the dendritic field. Bax-KO retinas exhibited a threefold increase in dendritic coverage. Each cell, however, contributed less dendrites at each depth within the plexus, intermingling their processes with those of neighboring cells to approximate a constant volumetric density, yielding a uniformity in process coverage across the population.SIGNIFICANCE STATEMENT Different types of retinal neuron spread their processes across the surface of the retina to achieve a degree of dendritic coverage that is characteristic of each type. Many of these types achieve a constant coverage by varying their dendritic field area inversely with the local density of like-type neighbors. Here we report a population of retinal amacrine cells that do not develop dendritic arbors in relation to the spatial positioning of such homotypic neighbors; rather, this cell type modulates the extent of its dendritic branching when faced with a variable number of overlapping dendritic fields to approximate a uniformity in dendritic density across the retina. 相似文献
2.
3.
4.
5.
6.
7.
William G. Breen Krishan R. Jethwa Nathan Y. Yu Grant M. Spears William S. Harmsen Robert C. Miller Jonathan B. Ashman William G. Rule Terence T. Sio Michelle A. Neben-Wittich Michael G. Haddock Amit Mahipal Mark J. Truty Christopher L. Hallemeier Kenneth W. Merrell 《Practical radiation oncology》2021,11(1):e63-e69
PurposeOur purpose was to determine the effect of chemoradiotherapy (CRT) on patient-reported quality of life (QOL) for patients with intact pancreas cancer.Methods and MaterialsWe reviewed a prospective QOL registry for patients with intact, clinically localized pancreatic ductal adenocarcinoma treated with CRT between June 2015 and November 2018. QOL was assessed pre-CRT (immediately before CRT, after neoadjuvant chemotherapy) and at the completion of CRT with the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) and its component parts: FACT-General (FACT-G) and hepatobiliary cancer subscore (HCS). A minimally important difference from pre-CRT was defined as ≥ 6, 5, and 8 points for FACT-G, HCS, and FACT-Hep, respectively.ResultsOf 157 patients who underwent CRT, 100 completed both pre- and post-CRT surveys and were included in the primary analysis. Median age at diagnosis was 65 years (range, 23-90). National Comprehensive Cancer Network resectability status was resectable (3%), borderline resectable (40%), or locally advanced (57%). Folinic acid, 5-fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) (75%) or gemcitabine and nab-paclitaxel (42%) were given for a median of 6 cycles (range, 0-42) before CRT. Radiation therapy techniques included 3-dimensional conformal (22%), intensity modulated photon (55%), and intensity modulated proton (23%) radiation therapy to a median dose of 50 Gy (range, 36-62.5). Concurrent chemotherapy was most commonly capecitabine (82%). Sixty-three patients (63%) had surgery after CRT. The mean decline in FACT-G, HCS subscale, and FACT-Hep from pre- to post-CRT was 3.5 (standard deviation [SD], 13.7), 1.7 (SD 7.8), and 5.2 (SD 19.4), respectively. Each of these changes were statistically significant, but did not meet the minimally important difference threshold. Pancreatic head tumor location was associated with decline in FACT-Hep. Nausea was the toxicity with the greatest increase from pre- to post-CRT by both physician-assessment and patient-reported QOL.ConclusionsFor patients with intact pancreatic adenocarcinoma, modern CRT is well tolerated with minimal decline in QOL during treatment. 相似文献
8.
9.
10.